Neurogastrx, Inc. — Form D
Neurogastrx, Inc. of WOBURN, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-07-06. $20.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-07-06
- Form: D
- Accession: 0001870700-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Amount sold: $20.0M
- Investors: 4
- Date of first sale: 2021-06-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-405343
Issuer
- Name: Neurogastrx, Inc.
- CIK: 0001870700
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 600 UNICORN PARK DRIVE, WOBURN, MA, 01801
- Phone: 781-730-4606
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Klaus Veitinger | Director | Chanhassen, MN |
| Aaron Royston | Director | Cambridge, MA |
| David Allison | Director | Westlake Village, CA |
| JAMES O'MARA | Director | NEW YORK, NY |
| JAMES O'MARA | Executive Officer | NEW YORK, NY |
| CYRIL DE COLLE | Director | WOBURN, MA |
| CYRIL DE COLLE | Executive Officer | WOBURN, MA |
| KLAUS VETTINGER | Director | WOBURN, MA |
| JAMES DETORE | Executive Officer | WOBURN, MA |
| PAUL ROGERS | Executive Officer | WOBURN, MA |
| KEVIN KOCH | Director | WOBURN, MA |
Other filings by this issuer (1)
More